bpc-157/tb-500 blend 5/5mg reconstitution BPC-157 / TB-500 CAPSULES How to Reconstitute BPC-157 +

| Protocol Type | Tirzepatide Dose | 5-Amino-1MQ Dose | Administration Frequency | Expected Mechanism | Typical Observation Window | Professional Assessment | ||||||| | Tirzepatide Monotherapy | 2.515mg weekly (titrated) | None | Weekly subcutaneous injection | GLP-1/GIP receptor agonism reduces appetite and slows gastric emptying | 1220 weeks to plateau | Proven efficacy in human trials

Its mainly used to correct or prevent a B12 shortfall, and to support general energy and wellbeing where a shortfall is the likely cause

Lack of intrinsic factor is most common in older people and is usually associated with an autoimmune disease known as pernicious anaemia

References Falutz J, et al

Good to know about b12, I always when available bought more than enough then disposed when out of date except on that one occasion